Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Welcure Drugs & Pharmaceuticals (BOM:524661) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Welcure Drugs & Pharmaceuticals's EV-to-EBIT for today is
Welcure Drugs & Pharmaceuticals's current Enterprise Value is ₹291 Mil.
Welcure Drugs & Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-59 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Welcure Drugs & Pharmaceuticals's EV-to-EBITDA for today is:
Welcure Drugs & Pharmaceuticals's current Enterprise Value is ₹291 Mil.
Welcure Drugs & Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-59 Mil.
Welcure Drugs & Pharmaceuticals's current Enterprise Value is ₹291 Mil.
Welcure Drugs & Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,655 Mil.
Welcure Drugs & Pharmaceuticals's current Enterprise Value is ₹291 Mil.
Welcure Drugs & Pharmaceuticals's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
Welcure Drugs & Pharmaceuticals's current Enterprise Value is ₹291 Mil.
Welcure Drugs & Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welcure Drugs & Pharmaceuticals Enterprise Value Related Terms
Welcure Drugs & Pharmaceuticals Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welcure Drugs & Pharmaceuticals Enterprise Value Chart
BOM:524661 vs MCK, COR, CAH: Enterprise Value Comparison
For the Medical Distribution subindustry, Welcure Drugs & Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcure Drugs & Pharmaceuticals Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Welcure Drugs & Pharmaceuticals's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Welcure Drugs & Pharmaceuticals's Enterprise Value falls into.
Welcure Drugs & Pharmaceuticals Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welcure Drugs & Pharmaceuticals (BOM:524661) has a Enterprise Value of ₹291 Mil as of Jul. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Welcure Drugs & Pharmaceuticals and its competitors.
Is Welcure Drugs & Pharmaceuticals' Enterprise Value too high?
Welcure Drugs & Pharmaceuticals' current Enterprise Value is ₹291 Mil. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' Enterprise Value compare to MCK and COR?
Welcure Drugs & Pharmaceuticals' Enterprise Value of ₹291 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. Welcure Drugs & Pharmaceuticals's current Enterprise Value is ₹291 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current Enterprise Value of ₹291 Mil. The current Enterprise Value is ₹291 Mil. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current Enterprise Value is ₹291 Mil as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Welcure Drugs & Pharmaceuticals Business Description
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
19GF Score
Get the complete analysis for BOM:524661
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524661 has been successfully added to your 
